These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7886110)

  • 21. Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm.
    Lamont EW; Kokkinidis L
    Brain Res; 1998 Jun; 795(1-2):128-36. PubMed ID: 9622611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats.
    Schulz B; Fendt M; Gasparini F; Lingenhöhl K; Kuhn R; Koch M
    Neuropharmacology; 2001 Jul; 41(1):1-7. PubMed ID: 11445180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonextinction procedure for long-term studies of classically conditioned enhancement of acoustic startle in the rat.
    Winston CR; Leavell BJ; Ardayfio PA; Beard C; Commissaris RL
    Physiol Behav; 2001 May; 73(1-2):9-17. PubMed ID: 11399289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbachol injections into the nucleus accumbens disrupt acquisition and expression of fear-potentiated startle and freezing in rats.
    Schwienbacher I; Schnitzler HU; Westbrook RF; Richardson R; Fendt M
    Neuroscience; 2006 Jul; 140(3):769-78. PubMed ID: 16581194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions.
    Langton JM; Richardson R
    Neuropsychopharmacology; 2008 Dec; 33(13):3096-102. PubMed ID: 18354389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm.
    Missig G; Ayers LW; Schulkin J; Rosen JB
    Neuropsychopharmacology; 2010 Dec; 35(13):2607-16. PubMed ID: 20844476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine injections into the nucleus accumbens affect neither acquisition/expression of conditioned fear nor baseline startle response.
    Schwienbacher I; Fendt M; Schnitzler HU
    Exp Brain Res; 2005 Jan; 160(4):538-44. PubMed ID: 15650891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fear-potentiated startle in rats.
    Davis M
    Curr Protoc Neurosci; 2001 May; Chapter 8():Unit 8.11A. PubMed ID: 18428539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of contextual fear in the anxiolytic effect of chlordiazepoxide in the fear-potentiated startle test.
    Zhao Y; Bijlsma EY; Verdouw PM; Garssen J; Groenink L
    Behav Brain Res; 2018 Nov; 353():57-61. PubMed ID: 29969605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues.
    Baker KD; McNally GP; Richardson R
    Learn Mem; 2012 Sep; 19(10):461-9. PubMed ID: 22984284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control conditions in the fear-potentiated startle response paradigm.
    Joordens RJ; Hijzen TH; Peeters BW; Olivier B
    Neuroreport; 1997 Mar; 8(4):1031-4. PubMed ID: 9141086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fear-potentiated startle conditioning in humans: explicit and contextual cue conditioning following paired versus unpaired training.
    Grillon C; Davis M
    Psychophysiology; 1997 Jul; 34(4):451-8. PubMed ID: 9260498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AX+, BX- discrimination learning in the fear-potentiated startle paradigm: possible relevance to inhibitory fear learning in extinction.
    Myers KM; Davis M
    Learn Mem; 2004; 11(4):464-75. PubMed ID: 15254216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.
    Grillon C; Heller R; Hirschhorn E; Kling MA; Pine DS; Schulkin J; Vythilingam M
    Biol Psychiatry; 2011 Mar; 69(6):549-55. PubMed ID: 21277566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction.
    Walker DL; Davis M
    Pharmacol Biochem Behav; 2002 Mar; 71(3):379-92. PubMed ID: 11830172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latent inhibition of fear potentiated startle in rats.
    Schauz C; Koch M
    Behav Pharmacol; 1998 Mar; 9(2):175-8. PubMed ID: 10065937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual cortex ablations do not prevent extinction of fear-potentiated startle using a visual conditioned stimulus.
    Falls WA; Davis M
    Behav Neural Biol; 1993 Nov; 60(3):259-70. PubMed ID: 8297322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extinction deficit and fear reinstatement after electrical stimulation of the amygdala: implications for kindling-associated fear and anxiety.
    Kellett J; Kokkinidis L
    Neuroscience; 2004; 127(2):277-87. PubMed ID: 15262319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine and naloxone: effects on conditioned fear as measured with the potentiated startle paradigm.
    Davis M
    Eur J Pharmacol; 1979 Mar; 54(4):341-7. PubMed ID: 436933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct contributions of median raphe nucleus to contextual fear conditioning and fear-potentiated startle.
    Silva RC; Cruz AP; Avanzi V; Landeira-Fernandez J; Brandão ML
    Neural Plast; 2002; 9(4):233-47. PubMed ID: 12959153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.